Global Liquid Biopsy Market 2018-2024
23-Jun-2018 | Number of pages: 184 | Report Id: BMRC MD 121 | Report Format: | Status: Published

Liquid Biopsy Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024

Brandessence Market Research is working on a new report title “Liquid Biopsy Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024.  Increasing prevalence of cancer and rising demand for non-invasive procedures are key drivers for Global Liquid Biopsy Market.

Scope of Global Liquid Biopsy Market Reports –

Liquid Biopsy is a unique and non-invasive alternative tool to surgical biopsies and helps in determining an array of information about tumors through a simple test sample. According to the International Agency for Research on Cancer, by 2030 there will be over 22 million new cases a year, up from 14 million in 2012. There is a significant rise in prevalence of cancer globally. So, during the study of Global Liquid Biopsy market, we have considered Liquid Biopsy products and consumables to analyze the market.

Global Liquid Biopsy Market report is segmented on the basis of Product type, Biomarker type, Sample type, Application Type, End User type and by regional & country level. Based on Product type global Liquid Biopsy Market is classified as Instruments, Kits and Services. Based upon Biomarker, global Liquid Biopsy Market is classified as Cell-free DNAs (cfDNAs), Circulating tumor cells (CTCs) and Exosomes. Based upon Sample type, global Liquid Biopsy Market is classified as Blood, Urine, Serum/Plasma and others. Based upon Application type, global Liquid Biopsy Market is classified as Lung Cancer, Leukemia, Gastrointestinal Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer and others. Based upon End User type, global Liquid Biopsy Market is classified as Hospitals, Diagnostic Laboratories and Cancer Research Centers.

The regions covered in this Liquid Biopsy Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Liquid Biopsy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Liquid Biopsy Market Reports-

Global Liquid Biopsy market report covers prominent players like QIAGEN, Adaptive Biotechnologies, Johnson & Johnson, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Cynvenio Biosystems, Inc., Epic Sciences, F. Hoffmann-La Roche Ltd., Genomic Health, Guardant Health, Inc., Illumina Inc., Janssen Diagnostics, MDxHealth, Menarini Silicon Biosystems, Myriad Genetics, Natera Inc., Pathway Genomics Corporation, NeoGenomics Laboratories, Inc., , RainDance Technologies, Inc., Silicon Biosystems, Thermo Fisher Scientific, Trovagene Inc., Sysmex Corporation and others.

Global Liquid Biopsy Market Dynamics –

Increasing number of cancer patients, improvements in diagnostic testing, advancements in immunotherapy and targeted approaches and rising demand of non-invasive diagnostic procedures and personalized medicine

Global Liquid Biopsy Market Regional Analysis –

North America dominates the market with highest market share due to increasing number of cancer incidences and increasing launch of new and advanced products. According to NCI (National Cancer Institute), Increasing prevalence of cancer and increased growth in research and development activities are majorly responsible on growth of Liquid Biopsy market in Europe. According to the  latest report by World Health Organization (WHO), Asia Pacific region anticipates to see a 70% increase in new cancer cases in the next two decades. Asia Pacific Liquid Biopsy Market is witnessed with strong growth rate majorly due high prevalence of cancer, increasing population, growing awareness regarding cure and treatment of cancer and government funding for research and development.

Key Benefits for Global Liquid Biopsy Market Reports –

  • Global Liquid Biopsy Market report covers in depth historical and forecast analysis.
  • Global Liquid Biopsy Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Liquid Biopsy Market report helps to identify opportunities in market place.
  • Global Liquid Biopsy Market report covers extensive analysis of emerging trends and competitive landscape.

Global Liquid Biopsy Market Segmentation –

Global Liquid Biopsy Market: by Product type Analysis

  • Instruments
  • Kits
  • Services

Global Liquid Biopsy Market: by Biomarker type Analysis

  • Cell-free DNAs (cfDNAs)
  • Circulating tumor cells (CTCs)
  • Exosomes
  • Others

Global Liquid Biopsy Market: by Sample type analysis

  • Blood
  • Urine
  • Serum/Plasma
  • Others

 Global Liquid Biopsy Market: by Application analysis

  • Lung Cancer
  • Leukemia
  • Gastrointestinal Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others

Global Liquid Biopsy Market: by End User Analysis

  • Hospitals
  • Diagnostic Laboratories
  • Cancer Research Centers

Global Liquid Biopsy Market: by Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Liquid Biopsy Market 2018-2024

Our 184 pages report provides 52 tables, 66 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024, significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Liquid Biopsy Market
  • To receive forecasts of Global Liquid Biopsy sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in the Global Liquid Biopsy sector
  • To determine the forces and factor that influences the market for Global Medical Robotics: drivers, restraints, opportunities and threats
  • To find out where the Global Liquid Biopsy Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by region and Country

Global Liquid Biopsy Market: By Region

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Global XX XX XX XX XX
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia Pacific XX XX XX XX XX
Latin America XX XX XX XX XX
Middle East & Africa XX XX XX XX XX
Global XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By Product Type

  2017

(USD Million)

     2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Instruments XX    XX      XX XX XX
Kits XX    XX     XX XX XX
Services XX    XX     XX XX XX
Total XX    XX     XX XX XX
             

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By Biomarker Type

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Cell-free DNAs (cfDNAs) XX XX XX XX XX
Circulating tumor cells (CTCs XX XX XX XX XX
Exosomes XX XX XX XX XX
Others
Total XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By Sample Type

  2017

(USD Million)

     2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Blood XX    XX      XX XX XX
Urine XX    XX     XX XX XX
Serum/Plasma XX    XX     XX XX XX
Others XX    XX      XX XX XX
Total XX    XX     XX XX XX
             

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By Application Type

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Lung Cancer XX    XX      XX XX XX
Leukemia XX    XX       XX XX XX
Gastrointestinal Cancer XX    XX       XX XX XX
Breast Cancer XX    XX     XX XX XX
Colorectal Cancer XX    XX     XX XX XX
Prostate Cancer XX    XX     XX XX XX
Others XX    XX      XX XX XX
Total      XX    XX        XX XX       XX
             

Source: Brandessence Market Research, 2018

Global Liquid Biopsy Market: By End User Type

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Hospitals and Clinics XX    XX      XX XX XX
Diagnostic Laboratories XX    XX     XX XX XX
Cancer Research Centers XX    XX     XX XX XX
Total XX    XX     XX XX XX
             

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey of the Global Liquid Biopsy with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

Companies Mentioned in This Report:

  • Qiagen
  • Adaptive Biotechnologies
  • Johnson & Johnson
  • Angle Plc.
  • Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • Cynvenio Biosystems Inc.
  • Epic Sciences
  • Hoffmann-La Roche Ltd.
  • Genomic Health
  • Guardant Health Inc.
  • Illumina Inc.
  • Janssen Diagnostics
  • Mdxhealth
  • Menarini Silicon Biosystems
  • Myriad Genetics, Natera Inc.
  • Pathway Genomics Corporation
  • Neogenomics Laboratories Inc.
  • Raindance Technologies Inc.
  • Silicon Biosystems
  • Thermo Fisher Scientific
  • Trovagene Inc.
  • Sysmex Corporation
  • Others

  • Qiagen
  • Adaptive Biotechnologies
  • Johnson & Johnson
  • Angle Plc.
  • Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • Cynvenio Biosystems Inc.
  • Epic Sciences
  • Hoffmann-La Roche Ltd.
  • Genomic Health
  • Guardant Health Inc.
  • Illumina Inc.
  • Janssen Diagnostics
  • Mdxhealth
  • Menarini Silicon Biosystems
  • Myriad Genetics, Natera Inc.
  • Pathway Genomics Corporation
  • Neogenomics Laboratories Inc.
  • Raindance Technologies Inc.
  • Silicon Biosystems
  • Thermo Fisher Scientific
  • Trovagene Inc.
  • Sysmex Corporation
  • Others